Abstract
The purine salvage pathways of pathogenic protozoa are of special interest because most of these organisms lack the ability to synthesize purines de novo. This absence of an alternative to salvage is the basis for the view that these pathogens might be particularly susceptible to selective chemotherapy with purine analogues and their nucleosides. The preceding paper provides some examples to illustrate the validity of this view. The central point of this paper is the comparison of purine salvage enzymes of two not so distantly related pathogenic protozoa. The basic lesson is that not only do pathogenic protozoa differ from mammals in their purine salvage enzymes, but dramatic diversity among the protozoa themselves can be found.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J.V. Tuttle and T.A. Krenitsky, Purine Phosphoribosyltrans- ferases from Leishmania donovani, J. BÃol. Chem. 255: 909 (1980).
G.W. Koszalka and T.A. Krenitsky, Nucleosidases from Leishmania donovani, J. Biol. Chem. 254: 8185 (1979).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Krenitsky, T.A., Miller, R.L. (1984). Purine Salvage Enzymes in Leishmania Donovani and Trichomonas Vaginalis . In: De Bruyn, C.H.M.M., Simmonds, H.A., Müller, M.M. (eds) Purine Metabolism in Man-IV. Advances in Experimental Medicine and Biology, vol 165. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4553-4_42
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4553-4_42
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4555-8
Online ISBN: 978-1-4684-4553-4
eBook Packages: Springer Book Archive